AI assistant
ARDELYX, INC. — Director's Dealing 2014
Jun 18, 2014
32003_dirs_2014-06-18_8e35dcbe-7343-43ff-8328-91632c594609.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2014-06-18
Reporting Person: CMEA Ventures VII LP (10% Owner)
Reporting Person: CMEA VENTURES VII (PARALLEL) LP (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Preferred Stock | $0.00 | Common Stock (857595) | Indirect | ||
| Series B Preferred Stock | $0.00 | Common Stock (2665716) | Indirect | ||
| Series A Preferred Stock | $0.00 | Common Stock (21989) | Indirect | ||
| Series B Preferred Stock | $0.00 | Common Stock (68351) | Indirect | ||
| Series B Preferred Stock Purchase Warrant | $0.09 | 2020-11-16 | Series B Preferred Stock (131912) | Indirect | |
| Series B Preferred Stock Purchase Warrant | $0.09 | 2021-04-14 | Series B Preferred Stock (43970) | Indirect | |
| Series B Preferred Stock Purchase Warrant | $0.09 | 2020-11-16 | Series B Preferred Stock (3382) | Indirect | |
| Series B Preferred Stock Purchase Warrant | $0.09 | 2021-04-14 | Series B Preferred Stock (1127) | Indirect |
Footnotes
F1: Each share of Series A and Series B Preferred Stock will automatically convert on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering.
F2: The securities are immediately convertible or exercisable, as applicable.
F3: The expiration date is not relevant to the conversion of these securities.
F4: Reflects a one-for-nine reverse split of the Issuer's stock effected immediately prior to the consummation of the Issuer's initial public offering.
F5: The shares are directly held by CMEA Ventures VII, LP.
F6: The shares are directly held by CMEA Ventures (Parallel) VII, LP.
F7: The Series B Preferred Stock Purchase Warrants will be automatically exercised on a net basis into shares of Series B Preferred Stock based on the final public offering price of the Company's Common Stock immediately prior to the consummation of the Issuer's initial public offering. Such warrants cease to be exercisable following such initial public offering.